The integration of pharmacotherapy and nonpharmacotherapy.
Miller
N S
NS
Department of Psychiatry, University of Illinois at Chicago 60612-7327, USA.
Smith
D E
DE
D000427:Alcohol Deterrents / Q000627:therapeutic use; D016739:Behavior, Addictive / Q000503:physiopathology / Q000628:therapy*; D003131:Combined Modality Therapy; D004198:Disease Susceptibility; D004221:Disulfiram / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D010342:Patient Acceptance of Health Care; D011613:Psychotherapy / Q000379:methods*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome
D000427:Alcohol Deterrents; D009292:Narcotic Antagonists; D011619:Psychotropic Drugs; D009271:Naltrexone; D004221:Disulfiram